SANA
Sana Biotechnology Inc
2.90$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +67.6% | -50.3% | +4.0% | +4.2% | +40.3% | -35.9% | -21.7% | +11.7% | -4.3% | -21.7% | -6.6% | – | |
| – | -11.9% | +14.6% | +25.2% | -5.4% | -40.2% | +9.1% | -5.6% | -17.4% | +15.7% | -10.7% | -5.7% | – | |
| – | +97.9% | -172.8% | – | -114.6% | – | -354.2% | – | – | +389.8% | -290.6% | – | – | |
| – | +529.0% | +12.8% | -17.6% | -68.7% | -89.3% | -68.8% | -17.6% | -63.4% | +2,029.3% | -67.0% | +462.8% | – | |
| – | -70.2% | -604.4% | – | +618.0% | +12.7% | -64.7% | -53.7% | -725.3% | -65.7% | – | -277.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +818.7% | +10,749.7% | -94.3% | -80.4% | -69.1% | +52.7% | -42.9% | +19,425.8% | -83.9% | -100.7% | – | – | |
| – | – | – | -196.7% | – | – | -5,551.2% | – | – | -198.1% | – | -324.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.